Paper · 42979256
Multi-omics in coronary atherosclerosis: mechanistic insights and advances in precision diagnosis and treatment.
Chen J and 7 others. Front Endocrinol (Lausanne), 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Multi-omics in coronary atherosclerosis: mechanistic insights and advances in precision diagnosis and treatment. Papers, record 42979256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42979256
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multi-omics in coronary atherosclerosis: mechanistic insights and advances in precision diagnosis and treatment.
- Journal
- Front Endocrinol (Lausanne)
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Multiomics | Major topic |
| Coronary Artery Disease | Major topic |
| Precision Medicine | Major topic |
| Humans | |
| Metabolomics | |
| Genomics | |
| Biomarkers | |
| Proteomics |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,001,873 | RNA N6-methyladenosine modulates endothelial atherogenic responses to disturbed flow in mice. | Elife | 2022 | https://conductscience.org/library/papers/35001873 | PubMed |
| 2 | 21,247,313 | A prospective natural-history study of coronary atherosclerosis. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21247313 | PubMed |
| 3 | 40,931,012 | Integrated single-cell atlas of human atherosclerotic plaques. | Nat Commun | 2025 | https://conductscience.org/library/papers/40931012 | PubMed |
| 4 | 41,220,154 | Metabolic Vulnerability Index and Atherosclerosis Incident: A Prospective Cohort Study From the UK Biobank. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/41220154 | PubMed |
| 5 | 41,393,100 | Single-cell multi-omics for precision cardiovascular and longevity medicine: from methods to clinical translation. | Front Aging | 2025 | https://conductscience.org/library/papers/41393100 | PubMed |
| 6 | 41,101,252 | Integrating multi-modal omics to identify therapeutic atherosclerosis pathways for coronary heart disease. | EBioMedicine | 2025 | https://conductscience.org/library/papers/41101252 | PubMed |
| 7 | 41,124,095 | A multi-omics approach uncovers causality of IL6R on endotypes of subclinical carotid atherosclerosis and the possible role of the IL6R/OSMR pathway. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/41124095 | PubMed |
| 8 | 40,398,293 | H3K27Me3 abundance is associated with a decreased barrier function of endothelial cells by directly silencing VE-cadherin expression. | Atherosclerosis | 2025 | https://conductscience.org/library/papers/40398293 | PubMed |
| 9 | 41,844,614 | Vascular smooth muscle cell state trajectories mediate molecular mechanisms of coronary disease risk. | Nat Commun | 2026 | https://conductscience.org/library/papers/41844614 | PubMed |
| 10 | 42,289,048 | Decoding disease and therapy through multiomics integration and systems analysis. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42289048 | PubMed |
1 to 10 of 92
See all 92 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42979256
GET https://conductscience.org/api/papers/v1/42979256/references?page=2